Sprout Health
Locked-in pricing at every dose
Cash-pay telehealth platform offering compounded semaglutide from $149/mo and tirzepatide from $199/mo with dose-locked pricing, no membership fees, and no required lab work.
Advertising disclosure: We may earn a commission if you sign up through this link, at no additional cost to you. This does not influence our ratings or recommendations — how we make money.
Medications Available
Pros
- Price locks at signup and never increases as your dose goes up
- No membership, consultation, or cancellation fees
- Oral compounded tirzepatide available for needle-averse patients
- Fast onboarding — prescriptions in as little as 48 hours
- No-contract subscription, cancel anytime
- NAD+ therapy available as an add-on
Cons
- Compounded medications are not FDA-approved
- No lab work required before starting treatment — a meaningful safety gap
- Most patients never speak with a clinician by video
- Available in 44 states, not all 50
- Customer review scores are mixed and inconsistent across sources
- Cash-pay only, no insurance accepted
- No coaching or behavioral support included
Compare Sprout Health With
See how Sprout Health stacks up against other providers
About Sprout Health
Sprout Health is a cash-pay telehealth platform focused exclusively on weight management, founded in 2023 and based in Encinitas, California. It operates at joinsprouthealth.com, connecting patients with independent licensed clinicians and partner compounding pharmacies.
Sprout is a technology and administrative platform rather than a medical practice. It handles intake, subscription management, customer support, and coordination between the patient, the prescribing clinician, and the pharmacy — the clinical decisions are made by independent providers.
How It Works
- Online Application — Complete an intake questionnaire
- Clinician Review — An independent licensed provider evaluates eligibility
- Prescription — Prescriptions can be issued in as little as 48 hours
- Pharmacy Fulfillment — A partner compounding pharmacy ships to your door
- Ongoing Refills — No-contract subscription you can cancel anytime
Pricing (July 2026)
| Medication | Advertised Rate | Notes |
|---|---|---|
| Compounded Semaglutide | Starting at $149/mo | Rate locks at signup |
| Compounded Tirzepatide | Starting at $199/mo | Rate locks at signup |
| Compounded NAD+ Therapy | Starting at $199/mo | Add-on, not a GLP-1 |
No membership fees, no consultation fees, no cancellation fees.
A note on price consistency. Sprout’s advertised starting rates and the ongoing rates reported by third-party reviewers do not always match — some sources cite ongoing pricing closer to $249/mo for semaglutide and $299/mo for tirzepatide after a promotional first month. Confirm your locked rate and what it applies to at checkout.
The Dose-Lock Advantage
Sprout’s most substantive differentiator is pricing that does not scale with dose. Most compounded GLP-1 providers charge progressively more as you titrate — commonly $50–$150/month extra at maintenance doses. Because GLP-1 therapy is typically a 6–12 month-plus commitment during which you titrate upward, a locked rate compounds into real savings over a full course of treatment. Compare total 12-month cost, not month-one cost.
Safety Considerations
Sprout does not require lab work before starting treatment, and most patients will not have a telehealth appointment with a clinician. This is a genuine convenience advantage and a genuine clinical tradeoff.
GLP-1 medications carry real contraindications — including personal or family history of medullary thyroid carcinoma and MEN2 syndrome — and can interact with existing conditions and medications. Baseline labs and a clinician conversation are how those risks normally get caught. If you have any complicating medical history, a provider with a more thorough intake is the safer choice.
Important Compounding Context
Sprout dispenses compounded medications, which are not FDA-approved and are not evaluated by the FDA for safety, effectiveness, or quality. With the semaglutide and tirzepatide shortages resolved and FDA enforcement activity increasing through 2026, the regulatory environment for compounded GLP-1s remains unsettled. Read our guide to compounded GLP-1 medications before committing to a long prepaid plan.
Availability
Sprout Health operates in 44 U.S. states. Verify your state is covered before starting an application.
Who Is This Best For?
- Patients who expect to titrate to high maintenance doses and want a locked rate
- Those who want the fastest possible path to a prescription
- Needle-averse patients interested in oral compounded tirzepatide
- Healthy patients without complicating medical history
Who Should Look Elsewhere?
- Anyone with cardiac, thyroid, GI, or pancreatic history that warrants a real workup
- Patients who want brand-name Wegovy or Zepbound
- Those who want coaching or behavioral support bundled in
- Patients in the six states Sprout does not serve
The Bottom Line
Sprout Health’s dose-locked pricing is a legitimately good structure for anyone planning a full course of GLP-1 therapy, and the fee-free model is clean. But the speed comes from stripping out labs and clinician visits, and review sentiment is inconsistent enough that we would treat the convenience as a tradeoff rather than a pure win. Best suited to straightforward cases where a light-touch intake is clinically reasonable.
Last updated: July 2026
Last verified: July 2026
Ready to try Sprout Health?
Compare with other providers or visit their website to get started.